Navigation Links
Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010
Date:11/2/2010

ch and practice," noted Elizabeth van Thillo, Director of Marketing.

Along with the many Anesthesiologists across the US, Spectros is becoming a joining force in improving patient care and making sure that doctors can offer and maintain a safe and successful surgical experience.

About Spectros

Spectros markets and licenses advanced molecular sensing and imaging devices that shed light on ischemia and cancer. The company's champion product, the T-Stat VLS Tissue Oximeter, is the first medical device FDA-approved as sensitive to ischemia, an insufficient supply of oxygen to tissue.  T-Stat is the only commercially-available tissue oximeter that utilizes state-of-the-art multispectral visible light spectroscopy (VLS) technology.  The non-invasive T-Stat VLS system is used clinically to provide a continuous and real-time absolute value, utilizing 260 wavelengths, over the competing NIRS oximeter product lines that only use 2-4.

Spectros also develops molecular diagnostic tools for breast and prostate cancer, currently in phase I/II clinical trials supported by the National Cancer Institute.  Spectros is a venture-supported private concern and markets its products in the U.S. and internationally.

(Note:  Forward-looking statements are intended as a guide only, and do not constitute an offer for investment nor a guarantee of future events or returns.  Certain Spectros applications described above have not been reviewed and approved by the FDA, and are therefore labeled for investigational use only.  T-Stat and Continuum are trademarks of the Spectros Corporation.).

For further information, visit www.spectros.com.


'/>"/>
SOURCE Spectros
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
2. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
3. Spectros Corp. Enters Into Optical Biotechnology Patent Sale Agreement With Philips Electronics N.V.
4. Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
5. ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
8. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 U.S. ... yet only half of consumers surveyed are aware of ... ever used use them, according to findings from a ... community service partnership focused on improving the health and ... online survey polled 1,000 men and women, ages 21 ...
(Date:8/4/2015)... Ltd. (NASDAQ: ELOS ), a leading global aesthetic device ... ended June 30, 2015. Second Quarter ... , Revenue of $73.5 million, up 14% year-over-year, or ... grew 45% year-over-year. , International sales grew 8% year-over-year, ... the EMEA region and 25% product growth in the Asia-Pacific ...
(Date:8/3/2015)... 4, 2015   The Intellectual Property and ... leading provider of intelligent information for businesses and ... CMR Pharmaceutical R&D Factbook , the biopharmaceutical industry,s ... around declines in R&D, the analysis identifies a ... milestone and forecasts sales to reach $1.3 trillion ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Pharma Sales to Grow Beyond $1 Trillion 2
... HAMBURG , Feb. 3 , The International ... a global teleconference that will: , Detail the launch of ... its symposium in Hamburg being held February 5-6, ... develop a comprehensive, evidence-based consensus on the use of NPWT; ...
... BALTIMORE , Feb. 2 Celsis In Vitro, Inc. ... lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical ... District of Illinois in Chicago .  XenoTech and ... that certain processes and methods performed by XenoTech associated with its ...
Cached Medicine Technology:The International Negative Pressure Wound Therapy Expert Panel to Announce Results of Inaugural Symposium in Hamburg 2Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 2Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 3
(Date:8/4/2015)... ... August 04, 2015 , ... One of the nation’s leading experts in ... book, The Pain Antidote , which provides strategies for people who suffer from ... Chronic Pain Treatment Program, wrote the book in conjunction with Katherine Ketcham, an author ...
(Date:8/4/2015)... ... 2015 , ... Buckeye Health Plan is reminding parents to ... covered for members under the Healthchek program . , “Many schools have ... immunizations may not be allowed to attend when school begins in August,” said ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... with full examination now offered by the world renowned Beverly Hills facelift ... facial appearance through cosmetic surgery techniques helps individuals to achieve an outer appearance ...
(Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics heaven,” “mecca ... experience inside Naimie’s Beauty Center in LA. Now MENAJI is part of that experience ... , Naimie’s Beauty Center has been a favorite of makeup artists and hair pros ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... an automatic end to driving, says the August 2015 Harvard Health Letter. , ... to drive. It requires an individual assessment of skills," says Lissa Kapust, a ...
Breaking Medicine News(10 mins):Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2
... and Hollywood elite celebrated the launch of the ... Biomedical Skin Treatments - ... Fisher and beauty industry veteran Paul Scott Premo ... the heart of Los Angeles. (Photo: ...
... but some risks tied to dose strength, study says ... improves walking ability in some people with multiple sclerosis. , ... 18 to 70, the participants were randomly assigned to receive ... day for 14 weeks. The patients, walking speed was assessed ...
... 27 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(OTC ... a leading,manufacturer in the Chinese medical dressing ... that the European Patent Office has decided ... to Winner Medical. The,following are specifically covered ...
... (Nasdaq: ENDP ) announced today that it ... and market the investigational drug axomadol in the United ... entity discovered by Grunenthal and currently in Phase II ... chronic pain and diabetic peripheral neuropathic pain.Under the license ...
... to drive solid cash net income growthHAMILTON, Bermuda, Feb. 27 ... announced its results for the quarter and year ended December ... 2008 totaled $242.5 million, an increase of 6.5%, over the ... 2008 totaled $938.1 million, an increase of 4.3%, over the ...
... 27 Fourth quarter of 2008 as compared to ... UHT ) announced today that for the quarter ... or $.07 per diluted share, as compared to reported net ... the comparable quarter in the prior year. Included in net ...
Cached Medicine News:Health News:Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo 2Health News:Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo 3Health News:Drug Improves Mobility in Some MS Patients 2Health News:Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method 2Health News:Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method 3Health News:Endo Licenses Novel Pain Therapy from Grunenthal 2Health News:Endo Licenses Novel Pain Therapy from Grunenthal 3Health News:Endo Licenses Novel Pain Therapy from Grunenthal 4Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 2Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 3Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 4Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 5Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 6Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 7Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 8Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 9Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 10Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 11Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 12Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 13Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 14Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 15Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 16Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 17Health News:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008 18Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 2Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 3Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 4Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 5Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 6Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 7Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 8Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 9Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 10Health News:Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results 11
... variety of colors and classic shapes, ... designed with elegant jewel detail. With ... that are made from the same ... our fine timepieces, Timex branded frames ...
... captures the whimsy, charm and cutting edge ... design is inspired by Cynthia Rowley's creativity, ... from the Kenmark Group and B Robinson ... features eight optical and four sunwear designs ...
... collection offers a broad and definitive line ... value-minded consumer. The core line is a ... age and price sensitivity. The common theme ... high quality craftsmanship and a competitive price-versus-value ...
... The new Eyewear ... lifestyle proposition, encompassing elegance, ... well as a dedication ... Mirroring key attributes of ...
Medicine Products: